Trial Profile
Randomized,Single Center,Double Blind,Two-period,Crossover Glucose Clamp Trial to Test Bioequivalence Between Two Recombinant Human Soluble Insulins - Wockhardt's Insulin Human Regular for Injection and Actrapid, in Healthy Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Insulin (Primary)
- Indications Diabetes mellitus
- Focus Pharmacokinetics
- Sponsors Wockhardt
- 09 Nov 2008 Actual end date (Sep 2008) added as reported by ClinicalTrials.gov.
- 12 Oct 2008 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 11 Aug 2008 New trial record.